" Exactitude Consultancy That Adds Flavour To Your Success" Immunoassay Market size and trends. ELISA and CLIA diagnostics for infectious diseases, oncology, and endocrinology in hospital labs. The global Immunoassay Market is projected to reach USD 34.50 Billion in 2026 and USD 52.40 Billion by 2033, growing at a 6.1% CAGR. If you're looking for insights into the Immunoassay...

Sexually transmitted infections continue to represent a major public health challenge across the world, creating substantial demand for accurate, rapid, and accessible diagnostic solutions. Rising awareness regarding early disease detection, increasing prevalence of sexually transmitted infections, and expanding government screening initiatives are significantly contributing to the growth of...

The United States represents a significant market for drug abuse testing, driven by widespread workplace screening programs, strong regulatory oversight, and increasing efforts to combat substance abuse. Growing adoption of rapid testing technologies, rising awareness of public health concerns, and continued investments in diagnostic solutions are supporting market growth across healthcare, law...

The global viral antigens market is experiencing notable growth due to the increasing prevalence of infectious diseases, rising demand for advanced diagnostic technologies, and expanding investments in vaccine research and development. Viral antigens are widely used in disease detection, immunological research, and therapeutic development, making them an essential component of modern healthcare...

The Vitamin D Tests Market Trends indicate a strong shift toward automation, digitalization, and personalized healthcare diagnostics. One of the most significant trends is the increasing adoption of advanced laboratory technologies that provide faster and more accurate results. Healthcare providers are investing in high-throughput diagnostic systems that can process large volumes of...